• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞穿透肽偶联的 FADD 诱导癌细胞凋亡并调节炎症信号。

Cell-Penetrable Peptide-Conjugated FADD Induces Apoptosis and Regulates Inflammatory Signaling in Cancer Cells.

机构信息

Department of Cell Biology, School of Biological Sciences & Biotechnology, Indian Institute of Advanced Research, Koba Institutional Area, Gandhinagar 382 007, Gujarat, India.

出版信息

Int J Mol Sci. 2020 Sep 19;21(18):6890. doi: 10.3390/ijms21186890.

DOI:10.3390/ijms21186890
PMID:32961826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7555701/
Abstract

Dysregulated expression of Fas-associated death domain (FADD) is associated with the impediment of various cellular pathways, including apoptosis and inflammation. The adequate cytosolic expression of FADD is critical to the regulation of cancer cell proliferation. Importantly, cancer cells devise mechanisms to suppress FADD expression and, in turn, escape from apoptosis signaling. Formulating strategies, for direct delivery of FADD proteins into cancer cells in a controlled manner, may represent a promising therapeutic approach in cancer therapy. We chemically conjugated purified FADD protein with cell permeable TAT (transactivator of transcription) peptide, to deliver in cancer cells. TAT-conjugated FADD protein internalized through the caveolar pathway of endocytosis and retained in the cytosol to augment cell death. Inside cancer cells, TAT-FADD rapidly constituted DISC (death inducing signaling complex) assembly, which in turn, instigate apoptosis signaling. The apoptotic competency of TAT-FADD showed comparable outcomes with the conventional apoptosis inducers. Notably, TAT-FADD mitigates constitutive NF-κB activation and associated downstream anti-apoptotic genes , , , and , independent of pro-cancerous TNF-α priming. In cancer cells, TAT-FADD suppresses the canonical NLRP3 inflammasome priming and restricts the processing and secretion of proinflammatory IL-1β. Our results demonstrate that TAT-mediated intracellular delivery of FADD protein can potentially recite apoptosis signaling with simultaneous regulation of anti-apoptotic and proinflammatory NF-κB signaling activation in cancer cells.

摘要

Fas 相关死亡结构域(FADD)表达失调与多种细胞通路的抑制有关,包括细胞凋亡和炎症。FADD 的适当细胞内表达对于调节癌细胞增殖至关重要。重要的是,癌细胞会设计机制来抑制 FADD 的表达,从而逃避细胞凋亡信号。以受控方式将 FADD 蛋白直接递送至癌细胞的策略可能代表癌症治疗的一种有前途的治疗方法。我们通过化学方法将纯化的 FADD 蛋白与细胞穿透 TAT(转录激活因子)肽缀合,以递送至癌细胞中。TAT 缀合的 FADD 蛋白通过胞吞作用的小窝途径内化,并保留在细胞质中以增强细胞死亡。在癌细胞内,TAT-FADD 迅速构成 DISC(死亡诱导信号复合物)组装,进而引发细胞凋亡信号。TAT-FADD 的凋亡能力与传统的凋亡诱导剂具有可比的结果。值得注意的是,TAT-FADD 减轻了 NF-κB 的组成性激活和相关的下游抗凋亡基因 、 、 、 和 ,而不依赖于致癌性 TNF-α 引发。在癌细胞中,TAT-FADD 抑制经典的 NLRP3 炎性小体引发,并限制促炎 IL-1β 的加工和分泌。我们的研究结果表明,TAT 介导的 FADD 蛋白的细胞内递送至癌细胞内可能通过同时调节抗凋亡和促炎 NF-κB 信号通路的激活来重新激活细胞凋亡信号。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/e82c5f7ddd1c/ijms-21-06890-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/a2d7cbcd145b/ijms-21-06890-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/c292a218586b/ijms-21-06890-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/07d80bce0cce/ijms-21-06890-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/cb59c34f797f/ijms-21-06890-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/b2e24f3bb3bd/ijms-21-06890-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/e82c5f7ddd1c/ijms-21-06890-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/a2d7cbcd145b/ijms-21-06890-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/c292a218586b/ijms-21-06890-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/07d80bce0cce/ijms-21-06890-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/cb59c34f797f/ijms-21-06890-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/b2e24f3bb3bd/ijms-21-06890-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26b/7555701/e82c5f7ddd1c/ijms-21-06890-g006.jpg

相似文献

1
Cell-Penetrable Peptide-Conjugated FADD Induces Apoptosis and Regulates Inflammatory Signaling in Cancer Cells.细胞穿透肽偶联的 FADD 诱导癌细胞凋亡并调节炎症信号。
Int J Mol Sci. 2020 Sep 19;21(18):6890. doi: 10.3390/ijms21186890.
2
FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis.FADD调节核因子κB的激活,并促进cFLIPL的泛素化以诱导细胞凋亡。
Sci Rep. 2016 Mar 14;6:22787. doi: 10.1038/srep22787.
3
Expression of FADD and cFLIP balances mitochondrial integrity and redox signaling to substantiate apoptotic cell death.FADD和cFLIP的表达平衡线粒体完整性和氧化还原信号,以证实凋亡性细胞死亡。
Mol Cell Biochem. 2016 Nov;422(1-2):135-150. doi: 10.1007/s11010-016-2813-z. Epub 2016 Sep 13.
4
Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).一种对放线菌酮敏感的因子对死亡受体介导的基因诱导的抑制作用发生在Fas相关死亡结构域蛋白(FADD)水平或其上游。
J Biol Chem. 2000 Aug 11;275(32):24357-66. doi: 10.1074/jbc.M000811200.
5
Engagement of Fas differentially regulates the production of LPS-induced proinflammatory cytokines and type I interferons.Fas 结合可差异调节 LPS 诱导的促炎细胞因子和 I 型干扰素的产生。
FEBS J. 2019 Feb;286(3):523-535. doi: 10.1111/febs.14727. Epub 2018 Dec 22.
6
Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.显性负性FADD抑制TNFR60、Fas/Apo1和TRAIL-R/Apo2介导的细胞死亡,但不抑制基因诱导。
Curr Biol. 1998 Jan 15;8(2):113-6. doi: 10.1016/s0960-9822(98)70042-9.
7
HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells.HIV-TAT 融合 FHIT 蛋白在肝癌细胞中作为一种潜在的促凋亡分子发挥作用。
Biosci Rep. 2012 Jun;32(3):271-9. doi: 10.1042/BSR20110033.
8
IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.干扰素调节因子1抑制核因子κB活性,抑制肿瘤坏死因子受体相关因子2和细胞凋亡抑制蛋白1,并诱导乳腺癌细胞特异性生长抑制。
Cancer Biol Ther. 2015;16(7):1029-41. doi: 10.1080/15384047.2015.1046646.
9
Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.死亡结构域相关蛋白Fas(FADD)非依赖性地将c-FLIPL募集至死亡受体5。
J Biol Chem. 2004 Dec 31;279(53):55594-601. doi: 10.1074/jbc.M401056200. Epub 2004 Oct 14.
10
Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.在肿瘤坏死因子诱导的细胞凋亡过程中,Fas相关死亡结构域蛋白和半胱天冬酶-8不会被招募到肿瘤坏死因子受体1信号复合物中。
J Biol Chem. 2003 Jul 11;278(28):25534-41. doi: 10.1074/jbc.M303399200. Epub 2003 Apr 29.

引用本文的文献

1
Identification and characterization of eccDNA-driven genes in humans.人类中eccDNA驱动基因的鉴定与表征
PLoS One. 2025 Jun 6;20(6):e0324438. doi: 10.1371/journal.pone.0324438. eCollection 2025.
2
Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy.细胞凋亡,肿瘤与 T 细胞之间的代谢“正面交锋”:对免疫治疗的影响。
Cells. 2024 May 27;13(11):924. doi: 10.3390/cells13110924.
3
Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma.肺腺癌中预后免疫细胞动态平衡特征的鉴定和分析。

本文引用的文献

1
NF-κB in the New Era of Cancer Therapy.NF-κB 在癌症治疗的新纪元。
Trends Cancer. 2020 Aug;6(8):677-687. doi: 10.1016/j.trecan.2020.04.003. Epub 2020 May 11.
2
in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications.《癌症:表达与功能改变的机制及临床意义》
Cancers (Basel). 2019 Sep 29;11(10):1462. doi: 10.3390/cancers11101462.
3
Protein Delivery into the Cell Cytosol using Non-Viral Nanocarriers.使用非病毒纳米载体将蛋白质递送到细胞胞质溶胶中。
Clin Respir J. 2024 May;18(5):e13755. doi: 10.1111/crj.13755.
4
Cellular Dynamics of Fas-Associated Death Domain in the Regulation of Cancer and Inflammation.细胞 Fas 相关死亡结构域在癌症和炎症调控中的动力学。
Int J Mol Sci. 2024 Mar 12;25(6):3228. doi: 10.3390/ijms25063228.
5
The diagnostic or prognostic values of FADD in cancers based on pan‑cancer analysis.基于泛癌分析的FADD在癌症中的诊断或预后价值。
Biomed Rep. 2023 Sep 11;19(5):77. doi: 10.3892/br.2023.1659. eCollection 2023 Nov.
6
Insights of Endocytosis Signaling in Health and Disease.内吞作用信号转导在健康和疾病中的研究进展。
Int J Mol Sci. 2023 Feb 3;24(3):2971. doi: 10.3390/ijms24032971.
7
A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer.一种基于坏死性凋亡相关长链非编码RNA构建的膀胱癌新预后标志物
J Oncol. 2022 Nov 15;2022:5643496. doi: 10.1155/2022/5643496. eCollection 2022.
8
FADD as a key molecular player in cancer progression.FADD 作为癌症进展中的关键分子参与者。
Mol Med. 2022 Nov 8;28(1):132. doi: 10.1186/s10020-022-00560-y.
9
Chlorin e6 Phospholipid Delivery System Featuring APN/CD13 Targeting Peptides: Cell Death Pathways, Cell Localization, In Vivo Biodistribution.具有APN/CD13靶向肽的二氢卟吩e6磷脂递送系统:细胞死亡途径、细胞定位、体内生物分布
Pharmaceutics. 2022 Oct 18;14(10):2224. doi: 10.3390/pharmaceutics14102224.
10
Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma.肺腺癌预后、肿瘤微环境及药物敏感性中程序性细胞死亡特征的综合分析
Front Genet. 2022 May 18;13:900159. doi: 10.3389/fgene.2022.900159. eCollection 2022.
Theranostics. 2019 May 18;9(11):3280-3292. doi: 10.7150/thno.34412. eCollection 2019.
4
Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors.肽介导的血脑屏障药物传递系统用于靶向脑肿瘤。
Expert Opin Drug Deliv. 2019 Jun;16(6):583-605. doi: 10.1080/17425247.2019.1614911. Epub 2019 May 20.
5
S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.S194-P-FADD 作为人类 T 细胞淋巴母细胞淋巴瘤侵袭性和不良预后的标志物。
Carcinogenesis. 2019 Oct 16;40(10):1260-1268. doi: 10.1093/carcin/bgz041.
6
The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle shedding.经典的 NLRP3 炎性小体通过微泡脱落控制 FADD 的非常规分泌。
Cell Death Dis. 2019 Feb 25;10(3):190. doi: 10.1038/s41419-019-1412-9.
7
Recent Advances in Anti-cancer Protein/Peptide Delivery.抗癌蛋白/肽递药系统的最新进展。
Bioconjug Chem. 2019 Feb 20;30(2):305-324. doi: 10.1021/acs.bioconjchem.8b00750. Epub 2018 Nov 26.
8
FADD at the Crossroads between Cancer and Inflammation.FADD 在癌症与炎症的十字路口。
Trends Immunol. 2018 Dec;39(12):1036-1053. doi: 10.1016/j.it.2018.10.005. Epub 2018 Nov 3.
9
Recent developments in intracellular protein delivery.细胞内蛋白质递呈的最新进展。
Curr Opin Biotechnol. 2018 Aug;52:25-31. doi: 10.1016/j.copbio.2018.02.009. Epub 2018 Feb 24.
10
NF-κB, inflammation, immunity and cancer: coming of age.NF-κB、炎症、免疫与癌症:崭露头角。
Nat Rev Immunol. 2018 May;18(5):309-324. doi: 10.1038/nri.2017.142. Epub 2018 Jan 22.